{"date":"2025-08-07","count":83,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2025-08-07-2026-85w0hr","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"20:26:26","subject":"代重要子公司Belite Bio, Inc公告董事會決議以註冊直接發行方式辦理現金增資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-08-07 20:26，「代重要子公司Belite Bio, Inc公告董事會決議以註冊直接發行方式辦理現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-08-07-1920-1rob3cm","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"19:20:39","subject":"公告本公司董事會決議調整買回庫藏股事宜","clause":"第41款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-08-07 19:20，「公告本公司董事會決議調整買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-08-07-1919-xyhazt","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"19:19:34","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-08-07 19:19，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2025-08-07-1900-5j9o7v","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2025-08-07","time":"19:00:37","subject":"公告本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2025-08-07 19:00，「公告本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-08-07-1853-1bk4et6","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:53:18","subject":"公告本公司114年第一次現金增資基準日暨相關事宜","clause":"第9款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-08-07 18:53，「公告本公司114年第一次現金增資基準日暨相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-08-07-1852-2yp3wg","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:52:56","subject":"公告本公司決議向金融監督管理委員會申請調整114年第一次現金增資發行價格","clause":"第44款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-08-07 18:52，「公告本公司決議向金融監督管理委員會申請調整114年第一次現金增資發行價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-08-07-1852-5rax5d","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:52:23","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-08-07 18:52，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-08-07-1852-1xu4xk6","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:52:11","subject":"公告本公司董事會通過設置公司治理主管","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-08-07 18:52，「公告本公司董事會通過設置公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-08-07-1852-w2f525","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:52:01","subject":"公告本公司董事會通過114年度第二季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-08-07 18:52，「公告本公司董事會通過114年度第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2025-08-07-1827-1m6cne2","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:27:56","subject":"公告本公司內部稽核主管異動案。","clause":"第11款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2025-08-07 18:27，「公告本公司內部稽核主管異動案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2025-08-07-1827-1xtjtmq","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:27:19","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2025-08-07 18:27，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2025-08-07-1826-1ieuqii","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:26:52","subject":"公告本公司114年08月07日董事會重要決議事項","clause":"第44款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2025-08-07 18:26，「公告本公司114年08月07日董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-08-07-1810-xo2pc7","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"18:10:38","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第11款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-08-07 18:10，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-08-07-1810-aa2zln","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"18:10:11","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-08-07 18:10，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-08-07-1809-1a6mhq7","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"18:09:00","subject":"代子公司科進製藥科技股份有限公司公告114年第2季財務報表提報董事會","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-08-07 18:09，「代子公司科進製藥科技股份有限公司公告114年第2季財務報表提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-08-07-1805-1tahbdf","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-08-07","time":"18:05:57","subject":"代重要子公司佳醫資產管理事業股份有限公司公告董事、監察人任期屆滿重新指派","clause":"第6款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-08-07 18:05，「代重要子公司佳醫資產管理事業股份有限公司公告董事、監察人任期屆滿重新指派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-08-07-1801-1682awv","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:01:24","subject":"公告本公司產品總監新任案。","clause":"第11款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-08-07 18:01，「公告本公司產品總監新任案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-08-07-1801-pzjh8t","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:01:03","subject":"公告本公司董事會通過解除經理人競業禁止之限制。","clause":"第22款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-08-07 18:01，「公告本公司董事會通過解除經理人競業禁止之限制。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-08-07-1800-1ys7jom","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:00:46","subject":"公告本公司董事會決議發行114年限制員工權利新股暨訂定增資基準日。","clause":"第44款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-08-07 18:00，「公告本公司董事會決議發行114年限制員工權利新股暨訂定增資基準日。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-08-07-1800-93d62k","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:00:27","subject":"公告本公司董事會追認修正114年度限制員工權利新股發行辦法部分條文。","clause":"第9款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-08-07 18:00，「公告本公司董事會追認修正114年度限制員工權利新股發行辦法部分條文。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-08-07-1800-1ylri5l","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"18:00:04","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日。","clause":"第9款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-08-07 18:00，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-08-07-1759-91omib","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"17:59:44","subject":"公告本公司董事會通過114年第二季合併財務報表。","clause":"第43款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-08-07 17:59，「公告本公司董事會通過114年第二季合併財務報表。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2025-08-07-1754-1b1nu0x","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"17:54:14","subject":"公告本公司114年第二季財務報告業經提報董事會通過","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：天良（4127），2025-08-07 17:54，「公告本公司114年第二季財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2025-08-07-1747-ha84r7","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"17:47:30","subject":"代子公司New Path International Co., Ltd.依公開發行公司資金貸與及背書保證處理準則第25條第一項第一款規定公告背書保證予本公司","clause":"第22款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2025-08-07 17:47，「代子公司New Path International Co., Ltd.依公開發行公司資金貸與及背書保證處理準則第25條」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2025-08-07-1747-flch5n","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"17:47:14","subject":"本公司114年第2季合併財務報告經提報董事會通過","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2025-08-07 17:47，「本公司114年第2季合併財務報告經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-08-07-1744-1xv18rp","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"17:44:24","subject":"代重要子公司AMI公告辦理現金增資發行新股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-08-07 17:44，「代重要子公司AMI公告辦理現金增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-08-07-1739-ttc28i","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"17:39:32","subject":"代重要子公司Medeon International, Inc.公告辦理現金增資發行新股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-08-07 17:39，「代重要子公司Medeon International, Inc.公告辦理現金增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-08-07-1734-vwb8j4","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"17:34:13","subject":"公告本公司董事會通過會計主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-08-07 17:34，「公告本公司董事會通過會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-08-07-1729-1eym302","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"17:29:02","subject":"公告本公司114年第2季合併財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-08-07 17:29，「公告本公司114年第2季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2025-08-07-1722-1a4xke1","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2025-08-07","time":"17:22:13","subject":"公告本公司114年第2季合併財務報告董事會預計召開日期為114年8月13日","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2025-08-07 17:22，「公告本公司114年第2季合併財務報告董事會預計召開日期為114年8月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-08-07-1714-muluxb","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"17:14:33","subject":"公告本公司董事會決議通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-08-07 17:14，「公告本公司董事會決議通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-08-07-1658-1xtjtmq","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"16:58:03","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-08-07 16:58，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2025-08-07-1653-14xgnz2","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2025-08-07","time":"16:53:25","subject":"公告本公司114年第二季財務合併報告提報董事會。","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2025-08-07 16:53，「公告本公司114年第二季財務合併報告提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-08-07-1639-u295xg","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"16:39:54","subject":"公告本公司114年第二季合併財務報告業經提報董事會通過","clause":"第43款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-08-07 16:39，「公告本公司114年第二季合併財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2025-08-07-1635-xyhazt","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"16:35:59","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2025-08-07 16:35，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-08-07-1634-f2zhhz","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"16:34:20","subject":"公告本公司董事長訂定114年除權息基準日及調整配股率及配息率","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-08-07 16:34，「公告本公司董事長訂定114年除權息基準日及調整配股率及配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-08-07-1632-14napa2","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"16:32:28","subject":"公告本公司員工認股權憑證轉換普通股增資基準日(更正原114年7月16日之重大訊息)","clause":"第44款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-08-07 16:32，「公告本公司員工認股權憑證轉換普通股增資基準日(更正原114年7月16日之重大訊息)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-08-07-1631-hx12oz","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"16:31:01","subject":"公告本公司董事會決議委任第六屆薪酬委員會委員","clause":"第6款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-08-07 16:31，「公告本公司董事會決議委任第六屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-08-07-1630-36nmp4","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"16:30:01","subject":"公告本公司民國114年度第2季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-08-07 16:30，「公告本公司民國114年度第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-07-1616-1073zm2","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"16:16:41","subject":"董事會決議114年上半年度不分配股利","clause":"第14款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-07 16:16，「董事會決議114年上半年度不分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-08-07-1612-muluxb","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"16:12:32","subject":"公告本公司董事會決議通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-08-07 16:12，「公告本公司董事會決議通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2025-08-07-1607-39nikj","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"16:07:31","subject":"公告本公司董事會決議註銷庫藏股股數及訂定減資基準日","clause":"第11款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2025-08-07 16:07，「公告本公司董事會決議註銷庫藏股股數及訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2025-08-07-1607-xgsvcp","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"16:07:00","subject":"公告本公司114年第2季合併財務報告業經董事會決議通過","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2025-08-07 16:07，「公告本公司114年第2季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2025-08-07-1606-isqttc","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"16:06:15","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2025-08-07 16:06，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-08-07-1603-dljvw7","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"16:03:26","subject":"本公司董事會通過民國114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-08-07 16:03，「本公司董事會通過民國114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-08-07-1555-16dt62i","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"15:55:40","subject":"本公司與永信藥品工業股份有限公司簽訂合作開發暨授權合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-08-07 15:55，「本公司與永信藥品工業股份有限公司簽訂合作開發暨授權合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2025-08-07-1552-ssvjdi","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:52:54","subject":"公告本公司董事會決議通過設立子公司","clause":"第53款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2025-08-07 15:52，「公告本公司董事會決議通過設立子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-08-07-1552-o9qey3","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:52:40","subject":"公告本公司財務主管及代理發言人異動","clause":"第8款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-08-07 15:52，「公告本公司財務主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2025-08-07-1552-1eym302","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:52:33","subject":"公告本公司114年第2季合併財務報告經董事會決議通過","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2025-08-07 15:52，「公告本公司114年第2季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-08-07-1551-1da9nqa","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:51:53","subject":"公告本公司董事會同意修正114年度第一次員工認股權憑證發行及認股辦法部分條文","clause":"第11款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-08-07 15:51，「公告本公司董事會同意修正114年度第一次員工認股權憑證發行及認股辦法部分條文」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-08-07-1551-p9bs5i","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:51:26","subject":"公告本公司重要營運主管異動","clause":"第8款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-08-07 15:51，「公告本公司重要營運主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-08-07-1550-xyhazt","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-08-07","time":"15:50:54","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-08-07 15:50，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-08-07-1550-b9gsdb","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:50:50","subject":"公告本公司員工認股權憑證轉換普通股之增資基準日","clause":"第11款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-08-07 15:50，「公告本公司員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-08-07-1549-xyhazt","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:49:45","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-08-07 15:49，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-08-07-1547-1jvn9ia","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:47:39","subject":"公告本公司董事會提報民國114年第二季合併財務報表","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-08-07 15:47，「公告本公司董事會提報民國114年第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-08-07-1546-140kqs7","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:46:27","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-08-07 15:46，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-08-07-1542-aa2zln","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:42:43","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-08-07 15:42，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-08-07-1541-10r6y8q","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:41:07","subject":"代重要子公司Tulex Pharmaceuticals Inc.及Magnifica Inc.公告法人董事改派代表人","clause":"第6款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-08-07 15:41，「代重要子公司Tulex Pharmaceuticals Inc.及Magnifica Inc.公告法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-07-1520-q9mltn","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:20:11","subject":"公告本公司113年度盈餘分配現金股利之除息基準日","clause":"第14款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-07 15:20，「公告本公司113年度盈餘分配現金股利之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-07-1517-12d1z86","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:17:58","subject":"本公司114年第2季合併財務報告已提報董事會","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-07 15:17，「本公司114年第2季合併財務報告已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-08-07-1517-45tzht","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:17:42","subject":"代子公司碩創(上海)醫療器械有限公司公告-以辦理現金增資方式發行2025年員工認股計畫(員工認股權)","clause":"第11款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-08-07 15:17，「代子公司碩創(上海)醫療器械有限公司公告-以辦理現金增資方式發行2025年員工認股計畫(員工認股權)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-08-07-1515-tnxx6f","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:15:28","subject":"本公司及子公司對單一企業資金貸與符合資金貸與及背書保證處理準則第22條第1項第2、3款情事","clause":"第23款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-08-07 15:15，「本公司及子公司對單一企業資金貸與符合資金貸與及背書保證處理準則第22條第1項第2、3款情事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-08-07-1514-5lg2li","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:14:36","subject":"本公司董事會解除經理人競業禁止限制","clause":"第21款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-08-07 15:14，「本公司董事會解除經理人競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-08-07-1513-v42w3e","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:13:51","subject":"本公司董事會決議除權息基準日","clause":"第14款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-08-07 15:13，「本公司董事會決議除權息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-08-07-1512-3dteg3","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:12:52","subject":"本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-08-07 15:12，「本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-08-07-1505-1w2y2bb","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:05:35","subject":"公告本公司董事會決議股利配發基準日相關事宜","clause":"第14款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-08-07 15:05，「公告本公司董事會決議股利配發基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-08-07-1503-crufq3","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:03:44","subject":"公告本公司114年第2季合併財務報告業經董事會通過","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-08-07 15:03，「公告本公司114年第2季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-08-07-1502-11yxnae","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"15:02:16","subject":"公告本公司董事會決議通過114年第2季財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-08-07 15:02，「公告本公司董事會決議通過114年第2季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-08-07-1450-1mwk7sr","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"14:50:45","subject":"公告調整本公司國內第一次私募無擔保轉換公司債轉換價格","clause":"第53款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-08-07 14:50，「公告調整本公司國內第一次私募無擔保轉換公司債轉換價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-08-07-1432-1bkm0mx","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"14:32:53","subject":"公告本公司代理發言人異動","clause":"第8款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-08-07 14:32，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-08-07-1429-1vqatmd","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"14:29:05","subject":"公告本公司董事會決議解除代理財會主管競業禁止之限制","clause":"第21款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-08-07 14:29，「公告本公司董事會決議解除代理財會主管競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-08-07-1428-1a8xid6","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"14:28:09","subject":"公告本公司永續發展委員會成員異動","clause":"第6款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-08-07 14:28，「公告本公司永續發展委員會成員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-08-07-1421-1hve4u6","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"14:21:52","subject":"公告本公司財會主管異動","clause":"第8款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-08-07 14:21，「公告本公司財會主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-08-07-1420-3dteg3","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"14:20:19","subject":"本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-08-07 14:20，「本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-08-07-1418-27onoo","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"14:18:01","subject":"公告本公司董事會決議通過114年度第2季財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-08-07 14:18，「公告本公司董事會決議通過114年度第2季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-08-07-1417-1nnt8f1","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-08-07","time":"14:17:09","subject":"公告本公司董事會通過解除經理人競業禁止之限制","clause":"第21款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-08-07 14:17，「公告本公司董事會通過解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-08-07-1416-p3p2zc","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-08-07","time":"14:16:54","subject":"公告本公司董事會決議第一次買回庫藏股註銷減資基準日","clause":"第11款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-08-07 14:16，「公告本公司董事會決議第一次買回庫藏股註銷減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-08-07-1416-xyhazt","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-08-07","time":"14:16:38","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-08-07 14:16，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-08-07-1357-1ouaobe","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"13:57:47","subject":"公告本公司董事會通過114年第二季度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-08-07 13:57，「公告本公司董事會通過114年第二季度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-08-07-1352-1tset5h","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"13:52:57","subject":"生華科新藥CX-5461獲選由美國國家癌症研究所贊助五年抗癌計畫的第二項臨床試驗，用在治療具有特定 MYC 基因變異的B細胞淋巴瘤第1b/2期人體試驗已經向美國FDA提出IND申請。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-08-07 13:52，「生華科新藥CX-5461獲選由美國國家癌症研究所贊助五年抗癌計畫的第二項臨床試驗，用在治療具有特定 MYC 基因變異的B」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-08-07-1351-1vd893b","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"13:51:16","subject":"公告本公司董事會決議限制員工權利新股相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-08-07 13:51，「公告本公司董事會決議限制員工權利新股相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-08-07-1350-xyhazt","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-08-07","time":"13:50:41","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-08-07 13:50，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-08-07-1107-1ge4pkm","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-07","time":"11:07:53","subject":"公告本公司收受民事訴訟案件聲明上訴狀(對應114年1月20日公告)。","clause":"第2款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-08-07 11:07，「公告本公司收受民事訴訟案件聲明上訴狀(對應114年1月20日公告)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}